Patent · US Expired

Isoindole derivatives

US6777410B2 · kind B2 · utility

1Cited by
11References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 8, 2003
Grant dateAug 17, 2004
Priority date
Expiry dateApr 8, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to compounds represented by the general formula [I]wherein, R represents an azido group, etc., R1 and R2 are the same or different and represent hydrogen atoms, etc., R3 and R4 are the same or different and represent hydrogen atoms, etc., X1 represents an oxygen atom, etc., X2 represents an oxygen atom, etc., Y represents an oxygen atom, etc., and Z represents a condensed aryl group, etc., or a pharmaceutically acceptable salt thereof, preparation processes thereof, and an agent for treating diabetes, a prophylactic agent for chronic complications of diabetes or a drug against obesity, containing, as an effective ingredient, the compound or the pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.